Solventum Corporation (SOLV), with a market capitalization of approximately $14.5 billion, is a global healthcare company that develops solutions using health, material, and data science. The Eagan, Minnesota-based company’s technologies help healthcare professionals improve patient outcomes, enhance efficiency, and deliver better, smarter, safer care.
Shares of this leading healthcare company have slightly underperformed the broader market over the past year. SOLV has gained 16.2% over this period, while the broader S&P 500 Index ($SPX) has rallied 20.6%. On a year-to-date basis, SOLV has also underperformed, gaining 9.1% compared with the index’s 13.9% gain over the same period.
